|
|
Rai Staging System for Chronic Lymphocytic Leukemia
|
Stage
|
Clinical Features
|
|
0
|
Lymphocytosis (L) >5,000ml
|
|
I
|
L + enlarged nodes
|
|
II
|
L + hepato-/splenomegaly
(+/- nodes)
|
|
III
|
L + anemia (Hgb < 11g/dl)
(+/- hepato-/splenomegaly;
+/- nodes)
|
|
IV
|
L + thrombocytopenia
(< 100,000ml; +/- nodes;
+/- hepato-/splenomegaly;
+/- anemia)
|
Reference: Rai KR, Sawitsky A, Cronkite EP, et al. Clinical staging of chronic lymphocytic leukemia. Blood. 1975; 46:219-234.
Binet Classification for Chronic Lymphocytic Leukemia
|
Stage
|
Clinical Features*
|
|
A
|
L + <3 nodal regions enlarged
|
|
B
|
L + 3 or more nodal regions enlarged
|
|
C
|
L + anemia (Hgb < 10g/dl) and/or platelets < 100,000/ml (+/- nodal enlargement.
|
* Nodal Regions - maximum of 5 involved regions:
- cervical & Waldeyer ring
- axillae
- inguinal
- spleen
- liver
Reference: Binet JL, Auquier A, Dighiero G, et al. A new prognostic classification of chronic lymphocytic leukemia derived from a multivariate survival analysis. Cancer. 1981; 48:198-206.
Please see full Prescribing Information for FLUDARA®.
Distributed by Bayer HealthCare Pharmaceuticals Inc., Wayne, NJ 07470
Manufactured by Ben Venue Laboratories, Bedford, OH 44146
|